Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
AYTU BioPharma
AYTU
$23.9M
| $217K | ﹤0.01% |
71,323
+2,400
| +3% | +$6.87K |
|
|
RGLS
3202
DELISTED
Regulus Therapeutics
RGLS
| $217K | ﹤0.01% |
75,500
+20,900
| +38% | +$34.1K |
|
3203
Lindblad Expeditions
LIND
$1.94B
| $216K | ﹤0.01% |
+23,200
| New | +$214K |
|
3204
Surrozen
SRZN
$258M
| $216K | ﹤0.01% |
13,726
+3,400
| +33% | +$38.1K |
|
3205
Anixa Biosciences
ANIX
$116M
| $215K | ﹤0.01% |
+68,800
| New | +$274K |
|
3206
Armata Pharmaceuticals
ARMP
$167M
| $215K | ﹤0.01% |
51,396
-2,200
| -4% | -$7.96K |
|
3207
Blue Ridge Bankshares
BRBS
$315M
| $215K | ﹤0.01% |
80,051
+38,551
| +93% | +$105K |
|
3208
iShares Global REIT ETF
REET
$5.09B
| $213K | ﹤0.01% |
+9,000
| New | +$211K |
|
|
SPRB
3209
Spruce Biosciences
SPRB
$118M
| $213K | ﹤0.01% |
3,613
+1,145
| +46% | +$291K |
|
3210
NB Bancorp
NBBK
$1.01B
| $212K | ﹤0.01% |
+15,500
| New | +$217K |
|
|
SYBX
3211
DELISTED
Synlogic
SYBX
| $212K | ﹤0.01% |
118,435
+63,805
| +117% | +$167K |
|
3212
Senseonics Holdings Inc
SENS
$263M
| $211K | ﹤0.01% |
19,830
-25,775
| -57% | -$299K |
|
3213
Outlook Therapeutics
OTLK
$183M
| $210K | ﹤0.01% |
17,600
+12,329
| +234% | +$99.7K |
|
|
WDH
3214
Waterdrop
WDH
$402M
| $210K | ﹤0.01% |
162,736
+136,536
| +521% | +$152K |
|
3215
authID Inc
AUID
$12.1M
| $209K | ﹤0.01% |
27,428
+7,800
| +40% | +$73.8K |
|
3216
Richmond Mutual Bancorp
RMBI
$251M
| $208K | ﹤0.01% |
18,742
+1,300
| +7% | +$14.8K |
|
3217
SB Financial Group
SBFG
$164M
| $208K | ﹤0.01% |
15,125
-118
| -0.8% | -$1.73K |
|
3218
Offerpad Solutions
OPAD
$18.3M
| $207K | ﹤0.01% |
2,555
-820
| -24% | -$71.9K |
|
|
VIRX
3219
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $207K | ﹤0.01% |
202,499
+23,600
| +13% | +$17.2K |
|
3220
Katapult Holdings
KPLT
$30.4M
| $206K | ﹤0.01% |
17,700
+2,796
| +19% | +$34.7K |
|
3221
MIND Technology
MIND
$45.3M
| $205K | ﹤0.01% |
44,940
-900
| -2% | -$5.27K |
|
3222
Schwab International Small-Cap Equity ETF
SCHC
$5.39B
| $204K | ﹤0.01% |
5,700
-4,023
| -41% | -$138K |
|
|
VIGL
3223
DELISTED
Vigil Neuroscience
VIGL
| $204K | ﹤0.01% |
+59,964
| New | +$187K |
|
3224
Key Tronic
KTCC
$42.8M
| $203K | ﹤0.01% |
43,600
+6,300
| +17% | +$28.7K |
|
|
DOMA
3225
DELISTED
Doma Holdings, Inc.
DOMA
| $203K | ﹤0.01% |
44,807
+1,400
| +3% | +$6.13K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.